StocksTelegraph
S&P 500—NASDAQ—DOW—RUSSELL—
NASDAQ · NXL·Healthcare

Nexalin Technology, Inc. Stock Analysis & AI Score

Nexalin Technology, Inc. (NXL) has an ST Score of 26.3 (D+), driven by its Financial Strength (B) and held back by its Momentum (F). Analysts rate it Buy.

Market Closed
$4.35
Prev Close
—
Market Cap
—
Day Range
—
52W Range
—
P/E
—
EPS (TTM)
—
Volume
—
Avg —
Beta
—
26
ST Score
26.3/100D+

Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.

As of
AI Daily Briefing
Analysis by AI
Price History
—
Technical Indicators
FMP
Earnings Surprises
Analyst Forecast
Revenue Mix

Company Information

Employees—
CEO—
SectorHealthcare
IndustryMedical - Devices
IPO Date—
Website—
Country—
ExchangeNASDAQ

SEC Filings

Annual Report (10-K)

Filing DateAcceptedLink
Loading…

Quarterly Report (10-Q)

Filing DateAcceptedLink
Loading…
Analyst Price Target
ESG Score
Latest News

ST Score

NXL
26.3out of 100
Grade D+

Nexalin Technology, Inc. (NXL) has an ST Score of 26.3 (D+), driven by its Financial Strength (B) and held back by its Momentum (F). Analysts rate it Buy.

Strongest
Financial StrengthB
Weakest
MomentumF
All factor grades
  • Financial StrengthB
  • ValuationC
  • GrowthD+
  • ProfitabilityF
  • MomentumF
  • Piotroski3/9
Score methodology
Press Releases

Contact

NXL stock: frequently asked questions

What is NXL's ST Score?

Nexalin Technology, Inc. (NXL) has an ST Score of 26.3 (D+), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.

Is NXL a buy, hold, or sell?

Analysts rate NXL a Buy. Our ST Score grades it D+ (26.3/100). The ST Score is a data-driven signal, not a recommendation.

What are NXL's factor grades?

Valuation C, Profitability F, Financial Strength B, Momentum F, Growth D+.

What is NXL's valuation grade?

Nexalin Technology, Inc. (NXL) earns a valuation grade of C, measured against Medical - Devices peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.

What is NXL's growth grade?

Nexalin Technology, Inc. (NXL) earns a growth grade of D+, measured against Medical - Devices peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.

What is NXL's profitability grade?

Nexalin Technology, Inc. (NXL) earns a profitability grade of F, measured against Medical - Devices peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.

What is NXL's financial strength grade?

Nexalin Technology, Inc. (NXL) earns a financial strength grade of B, measured against Medical - Devices peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.

What is NXL's Piotroski score?

Nexalin Technology, Inc. (NXL) has a Piotroski F-Score of 3 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.